WUHN logo

Wuhan General Group (China), Inc. Stock Price

OTCPK:WUHN Community·US$55.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

WUHN Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

WUHN Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk with weak fundamentals.

4 Risks
0 Rewards

Wuhan General Group (China), Inc. Key Details

US$80.4m

Revenue

US$65.8m

Cost of Revenue

US$14.5m

Gross Profit

US$25.1m

Other Expenses

-US$10.6m

Earnings

Last Reported Earnings
Dec 31, 2012
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About WUHN

Founded
n/a
Employees
n/a
CEO
Jeffrey Robinson
WebsiteView website
wuhn.org

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

Recent WUHN News & Updates

Recent updates

No updates